Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

From Research Optoacoustic Novelty To Imaging Established in Routine diagnostics

Project description

Innovative technology for molecular optical imaging in deep tissue

Multispectral optoacoustic tomography (MSOT) is an innovative technology that enables molecular optical imaging in deep tissue. The technology is non-invasive and allows assessment of the concentration and distribution of molecules in the body, providing clinically important information on oxygenation, inflammation and tissue fibrosis. Despite its demonstrated scientific and clinical value, MSOT is not commercially available for the clinical market and is currently limited to research environments. The EU-funded FRONTIER project is supporting iThera Medical from Germany in optimising and translating the MSOT system from a research environment to a routine clinical imaging application.

Objective

Multispectral optoacoustic tomography (MSOT) is an innovative biomedical imaging technology that allows for molecular imaging in deep tissue. This noninvasive technology enables assessment of the concentration and distribution of a variety of clinically important molecules in the body and uniquely delivers information of e.g. oxygenation, inflammation, and fibrotic changes. MSOT has already demonstrated significant scientific and clinical value across a range of diseases and applications, making it a promising tool to diagnose diseases and monitor treatment response. Despite these early successes, the technology is not yet commercially viable on the broad clinical market and currently remains effectively confined to a research environment. FRONTIER will provide iThera Medical the means to translate an optimized MSOT system (MSOT Frontier) from a research environment to application in routine clinical imaging, thereby providing clinicians worldwide a powerful new diagnostic tool.

Coordinator

ITHERA MEDICAL GMBH
Net EU contribution
€ 2 451 121,00
Address
ZIELSTATTSTRASSE 13
81379 Munchen
Germany

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 3 581 601,23